Atezolizumab vs Lithium Carbonate

## Atezolizumab vs Lithium Carbonate: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Lithium Carbonate**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Lithium Carbonate**: Modulates intracellular signaling via inositol and GSK-3 inhibition.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Lithium Carbonate — 18-36 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Lithium Carbonate — Li2CO3.

**Molecular Weight**: Atezolizumab — N/A; Lithium Carbonate — 73.8910 g/mol.

**Type**: Atezolizumab — Antibody; Lithium Carbonate — Small molecule.